SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Merger of Amicus Therapeutics, Inc. with ARYA Sciences Acquisition Corp IV

New York, New York--(Newsfile Corp. - October 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:

To: All Persons or Entities who purchased Amicus Therapeutics, Inc. (NASDAQ: FOLD) ("Amicus" or the "Company") stock prior to September 29, 2021.

You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the merger of Amicus with ARYA Sciences Acquisition Corp IV. Upon the closing of the transaction, Amicus will become the largest shareholder in Caritas with a ~36% ownership stake (assuming no redemptions by ARYA's shareholders) and retain co-development and commercialization rights to the Fabry and Pompe gene therapy programs as well as negotiation rights on select future muscular dystrophy programs.

To learn more about the action and your rights, go to:

https://www.zlk.com/mna2/amicus-therapeutics-inc-information-request-form

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

The Amicus merger investigation concerns whether the Board of Amicus has harmed stockholders by agreeing to enter into this transaction and whether all material facts have been properly disclosed to stockholders.

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington, D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/98573